- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 21/06 - Anabolic agents
Patent holdings for IPC class A61P 21/06
Total number of patents in this class: 413
10-year publication summary
|
12
|
16
|
13
|
28
|
58
|
40
|
26
|
22
|
18
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Acceleron Pharma Inc. | 349 |
15 |
| Société des Produits Nestlé S.A. | 9938 |
14 |
| Scholar Rock, Inc. | 129 |
11 |
| Nestec S.A. | 2608 |
8 |
| Regeneron Pharmaceuticals, Inc. | 4563 |
8 |
| Sorbonne Universite | 1357 |
8 |
| Avidity Biosciences, Inc. | 210 |
8 |
| N.V. Nutricia | 1082 |
7 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3352 |
6 |
| TdeltaS Limited | 106 |
6 |
| Association Institut de Myologie | 116 |
5 |
| Monash University | 725 |
5 |
| Abbott Laboratories | 2329 |
4 |
| Centre National de La Recherche Scientifique | 10830 |
4 |
| Massachusetts Institute of Technology | 10190 |
4 |
| President and Fellows of Harvard College | 6065 |
4 |
| Biophytis | 32 |
4 |
| Meiji Co., Ltd. | 734 |
4 |
| Veru Inc. | 48 |
4 |
| Glaxosmithkline Intellectual Property Development Limited | 773 |
3 |
| Other owners | 281 |